Delivery Order SPE2DB20D1110-SPE2DB23FK17U
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,257.96 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens with a completion date of September 8, 2023. Amerisourcebergen is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,612.34 for Ozempic 0.25-0.5 mg/dose pens. The award was made by the Defense Logistics Agency (DLA), a defense agency. The contract has a completion date of January 8, 2024 and uses a firm fixed price pricing structure. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,963.13 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,805.26 delivery order is for the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen 3 mL. The contract has an ultimate completion date of April 12, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award, valued at $8,824.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of December 22, 2023. This contract is a delivery order and has a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $9,297.54 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) for the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen with a 3 mL capacity. The contract has an ultimate completion date of April 12, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, including the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,366.34 Firm Fixed Price Delivery Order is for the supply of Ozempic 0.25-0.5 mg/dose pen 3 mL, a pharmaceutical product used for diabetes management. The contract has an ultimate completion date of February 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $32,913.64 firm-fixed-price delivery order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to support military and government healthcare programs. The contract has an ultimate completion date of December 7, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $8,959.79 firm fixed price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of July 31, 2024. AmerisourceBergen, a large pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ozempic 0.25-0.5 mg/dose pens. The $9,930.95 fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with Amerisourcebergen, valued at up to $999,999,999.00, that provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC serves...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB23FK17UDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,453.88 delivery order is for Ozempic 0.25-0.5 mg/dose pens and has a completion date of May 11, 2023. The contract is a firm fixed-price delivery order without any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veterans' healthcare programs globally. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.5k | 5/10/23 |